大数据战略下医药产业高质量发展协同共治路径研究——基于江苏省医药产业数字化转型与监管实际

    Research on Collaborative Governance Path of High-quality Development of Pharmaceutical Industry Under Big Data Strategy: Based on the Digital Transformation and Supervision of Pharmaceutical Industry in Jiangsu Province

    • 摘要:
      目的  探究大数据战略下中国医药产业高质量发展新路径。
      方法 梳理江苏省医药产业数字化转型实绩,总结发达国家医药产业数字化转型治理经验。
      结果 中国医药产业可积极借鉴国际医药“数转智监”的先进理念与实践,立足中国医药产业实际与发展阶段,聚焦数据要素驱动、信息同步能力与资源保障安全等关键领域加速数字化转型;同时,推动构建政府主导、企业主体、医疗机构协同、公众参与的多元共治格局,以提升监管效能与促进产业高质量发展。
      结论 基于RACI模型的高质量发展协同共治方案可以助力医药产业进行高效全周期管理。

       

      Abstract:
      OBJECTIVE  To explore the new path of high-quality development of China's pharmaceutical industry under the big data strategy.
      METHODS  Combed the actual performance of digital transformation of pharmaceutical industry in Jiangsu Province, and summarized the experience of digital transformation and governance of pharmaceutical industry in developed countries.
      RESULTS  China's pharmaceutical industry could actively draw on the advanced concepts and practices of international pharmaceutical "digital-intelligent supervision", based on the actual conditions and development stage of the domestic pharmaceutical sector, focusing on key areas such as data element-driven development, information synchronization capability, and resource security to accelerate digital transformation. At the same time, efforts should be made to promote the establishment of a diversified co-governance framework led by the government, with enterprises as the main body, coordinated by medical institutions, and involving public participation, in order to enhance regulatory efficiency and promote high-quality development of the industry.
      CONCLUSION  A collaborative governance programme for high quality development based on the RACI model can help the pharmaceutical industry with efficient full-cycle management.

       

    /

    返回文章
    返回